Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients

Figure 1

Proportions of rs738409 major allele homozygotes (white bars) and G/ allele carriers (colour bars), among controls with progressively more advanced METAVIR stages and in HCC cases. (a) Entire population; (b) major allele homozygotes for HSD17B13:TA; (c) carriers of the HSD17B13:TA variant allele. Error bars represent 95% confidence intervals.

(a)

(b)

(c)